VYSIONEER

vysioneer-logo

Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors. The company unlocks drug efficacy with lesion-level precision to de-risk and accelerate clinical trials.

#SimilarOrganizations #People #Website #More

VYSIONEER

Social Links:

Industry:
Artificial Intelligence (AI) Health Care Health Diagnostics Oncology Software

Founded:
2019-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.vysioneer.com

Total Employee:
11+

Status:
Active

Contact:
609-865-8659

Email Addresses:
[email protected]

Total Funding:
750 K USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API GStatic Google Static Content Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style OpenResty Next.js Fastly Hosted Ruby On Rails


Similar Organizations

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

bridge7-logo

bridge7

Bridge7 develops AI-powered consultation software that ensures patients receive care from cancer treatment centers.

infervision-logo

Infervision

Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.

navina-logo

Navina

Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.

oncora-medical-logo

Oncora Medical

Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.

pera-labs-logo

Pera Labs

Pera Labs develops digiceuticals and AI-powered solutions for fertility.

syllable-logo

Syllable

Syllable uses AI to transform the way healthcare systems initiate and cultivate relationships with patients.

Current Employees Featured

jen-tang-lu_image

Jen-Tang Lu
Jen-Tang Lu Co-Founder, President, Chief Executive Officer @ Vysioneer
Co-Founder, President, Chief Executive Officer

Founder


jen-tang-lu_image

Jen-Tang Lu

Official Site Inspections

http://www.vysioneer.com Semrush global rank: 9.46 M Semrush visits lastest month: 375

  • Host name: 76.76.21.21
  • IP address: 76.76.21.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vysioneer"

VYSIONEER

Jan 17, 2024 Vysioneer. Unlocking lesion-level insights to make oncology trials smaller and faster. Problem. Tumor heterogeneity. 60% of cancer patients develop a mixture of shrinking, โ€ฆSee details»

Vysioneer - Crunchbase Company Profile & Funding

Organization. Vysioneer . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Vysioneer is an oncology AI company that โ€ฆSee details»

Vysioneer - LinkedIn

Vysioneer is an oncology AI company. We aim to improve the clarity about tumor heterogeneity in cancer treatment with lesion-level data. Leveraging our FDA-cleared AI platform, we help โ€ฆSee details»

Vysioneer 2025 Company Profile: Valuation, Funding & Investors

Vysioneer General Information Description. Developer of a tumor auto-contouring platform designed to provide precision radiosurgery. The company's platform provides a system for โ€ฆSee details»

Vysioneer Company Profile | Management and Employees List

Vysioneer Profile and History Vysioneer is a leading AI solution provider, aiming to pioneer the transformation in Cancer Care using Artificial Intelligence. The company leverages its โ€ฆSee details»

Vysioneer - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 23, 2025 Vysioneer. has raised a total funding of $2.78M over 3 rounds. Its first funding round was on Sep 10, 2019. List of recent funding rounds of Vysioneer. Date of funding. โ€ฆSee details»

Vysioneer - Products, Competitors, Financials, Employees, โ€ฆ

Vysioneer focuses on leveraging artificial intelligence to improve oncology treatment efficacy within the pharma and biotech sectors. Its main offerings include an AI-powered platform that โ€ฆSee details»

Vysioneer - Funding, Financials, Valuation & Investors - Crunchbase

Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors. New. ... Experience the new Crunchbase, powered by AI . Experience โ€ฆSee details»

Vysioneer, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Vysioneer has also tested the device through an 18-month clinical integration at National Taiwan University Hospital (NTUH). According to the company, clinical findings showed that clinicians โ€ฆSee details»

About - Vysioneer

Vysioneer is an oncology AI company with a mission to use machine learning to bring therapies to cancer patients in need sooner. Our journey began with the belief that every tumor matters in โ€ฆSee details»

Vysioneer - Overview, News & Similar companies | ZoomInfo.com

Apr 4, 2021 Vysioneer is a leading AI solution provider, aiming to pioneer the transformation in Cancer Care using Artificial Intelligence. The company leverag es its proprietary deep learning โ€ฆSee details»

Vysioneer, Mary Bird Perkins Cancer Center Endeavor To Make โ€ฆ

Nov 10, 2020 Vysioneer is headquartered in Boston and has an office in Taipei, Taiwan. Find out more at www.vysioneer.com, and follow the company on Linkedin. About Mary Bird โ€ฆSee details»

Vysioneer - Contacts, Employees, Board Members, Advisors

Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. โ€ฆSee details»

Vysioneer Receives FDA Clearance on First-Ever Tumor Auto โ€ฆ

Apr 5, 2021 VBrain has been integrated through Vysioneer's partnership with Mary Bird Perkins Cancer Center, a cancer care organization headquartered in Baton Rouge, โ€ฆSee details»

VYSIONEER

Vysioneer. Unlocking lesion-level insights to make oncology trials smaller and faster. Problem. Tumor heterogeneity. 60% of cancer patients develop a mixture of shrinking, stable, and โ€ฆSee details»

Vysioneer Improves Precision Radiation Therapy with AI - NVIDIA โ€ฆ

Dec 9, 2019 Vysioneer is working towards FDA clearance for VBrain and plans to launch contouring AI models for medical images of other parts of the body. The company also plans โ€ฆSee details»

As a second set of eyes and hands for clinicians, VBrain ... - Vysioneer

Apr 4, 2021 VBrain has been integrated through Vysioneerโ€™s partnership with Mary Bird Perkins Cancer Center, a cancer care organization headquartered in Baton Rouge, Louisiana. โ€ฆSee details»

Vysioneer Announces Data Sharing Agreement with Pfizer to โ€ฆ

Feb 21, 2023 Vysioneer is a pioneer in applied artificial intelligence in oncology. With the world's largest database of lesion-level clinical data and a regulatory-grade AI platform, Vysioneer โ€ฆSee details»

Vysioneer

Sign In Reset Password. Sign in with GoogleSee details»

Pharma / Biotech - Vysioneer

Sno/asco 2023 | real-world data| in collaboration with stanford medicine. sdps-09 mixed response of brain metastases treated with osimertinib predicts inferior survival outcomes: an artificial โ€ฆSee details»

linkstock.net © 2022. All rights reserved